Trial Profile
Studying Neurons Using Glypromate
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 May 2006
Price :
$35
*
At a glance
- Drugs Glycine-proline-glutamate (Primary)
- Indications Cognition disorders
- Focus Adverse reactions; Pharmacokinetics; Registrational
- Acronyms SNUG
- Sponsors Neuren Pharmaceuticals
- 01 May 2006 New trial record.